Astrotech (NASDAQ: ASTC) completed a successful 1st Detect demo with DHS and TSA personnel; TRACER 1000 to be demonstrated at their annual meeting of shareholders on Dec. 7th in Austin, TX.
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect has entered into a Cooperative Research and Development Agreement with the DHS S&T Transportation Security Laboratory.
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect, in collaboration with The University of Texas Health Science Center, now called UT Health San Antonio, announced positive preliminary results in pre-clinical trials for the BreathDetect 1000 – a rapid bedside breathalyzer for detecting bacterial infections in the respiratory tract, such as hospital-acquired pneumonia (HAP).
1ST Detect Corporation, a subsidiary of Astrotech Corporation (NASDAQ: ASTC), announced the United States Patent and Trademark Office (USPTO) issued a key patent for increasing the performance of the company’s unique ion trap mass spectrometer used for chemical analysis and detection. 1ST Detect’s total patent count is now 17 U.S. and 6 international issued, and 7 U.S. and 10 international pending.
1ST Detect Corporation was awarded three patents by the United States Patent Office (USPTO) enabling the field use of ion trap chemical analyzers in harsh and demanding environments.